ProMIS Neurosciences (PMN) Profit After Tax (2021 - 2026)

ProMIS Neurosciences (PMN) has 6 years of Profit After Tax data on file, last reported at -$8.2 million in Q1 2026.

• Quarterly Profit After Tax fell 11.6% year-over-year to -$8.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$40.6 million (down 4249.22% YoY) and the FY2025 annual result came in at -$39.7 million, down 1529.33% from the prior year.
• Profit After Tax rose to -$8.2 million in Q1 2026, from -$10.7 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $9.3 million in Q3 2024 to a low of -$11.6 million in Q3 2025.
• A 5-year average of -$4.5 million and a median of -$3.6 million in 2024 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2024 — Profit After Tax surged 492.94% — and 2025, when it plunged 4399.93%.
• Tracing PMN's Profit After Tax over 5 years: stood at -$7.2 million in 2022, then jumped by 52.6% to -$3.4 million in 2023, then jumped by 93.0% to -$238207.0 in 2024, then sank by 4399.93% to -$10.7 million in 2025, then advanced by 23.5% to -$8.2 million in 2026.
• The last three Profit After Tax figures came in at -$8.2 million (Q1 2026), -$10.7 million (Q4 2025), and -$11.6 million (Q3 2025), per Business Quant data.